Liver Cancer
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Aug 7, 2008; 14(29): 4633-4642
Published online Aug 7, 2008. doi: 10.3748/wjg.14.4633
Figure 3
Figure 3 Proliferation of L-02 cell and HCC cells Bel-7402, HepG2 were shown in Figure 3A-C. The relative value of [3H]thymidine incorporation was measured after cells were treated with LV-shMAT2B. Percentage cell viability of L-02 cells and HCC cells Bel-7402. HepG2 were counted with MTT after cells were treated with LV-shMAT2B Figure 2D-F. It was seen that LV-shMAT2B can inhibit cell viability and proliferation of HCC cells but had no effect on normal liver cells.